INST scientists develop glowing nanosensor for rapid nicotine, cotinine detection

he innovation could pave the way for early and low-cost screening of smoking exposure and second-hand smoke biomarkers

Anlon Healthcare gets Brickwork rating withdrawal after facility closure

FDA clears Travere’s FILSPARI for expanded use in rare kidney disease

FDA presses 2,200+ companies to fix missing clinical trial results

Move amid evidence of widespread reporting gaps

India Pharma 2026 showcases sectoral transformation through four key plenary discussions

Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals

TARC Tripundra launches in-community medical facility with Fortis Gurugram

On-site medical room brings preventive care, routine consultations, and diagnostics closer to residents

Haemonetics gains FDA nod to expand VASCADE MVP XL for larger sheaths in heart procedures

The approval now covers procedures using 10-14F inner diameter and up to 17F outer diameter procedural sheaths

Eli Lilly launches once-daily weight-loss pill Foundayo

The once-daily oral medication is approved for adults with obesity or overweight who have weight-related medical conditions

India’s Dapagliflozin Moment: Why USFDA’s generic greenlight wave matters

In just the last few days, companies including Lupin, Biocon, Alembic Pharmaceuticals and Aurobindo Pharma have announced approvals for 5 mg and 10 mg tablets, all bioequivalent to Farxiga

RoosterBio taps MineBio to supercharge hMSC & exosome solutions in China